Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 97, Issue -, Pages 270-279Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2015.10.007
Keywords
Extracellular matrix (ECM); Chemotherapy; Chemoresistance; Metastasis; Tumor microenvironment; Ligands
Categories
Funding
- Max Planck Society
Ask authors/readers for more resources
The general progression of cancer drug development involves in vitro testing followed by safety and efficacy evaluation in clinical trials. Due to the expense of bringing candidate drugs to trials, in vitro models of cancer cells and tumor biology are required to screen drugs. There are many examples of drugs exhibiting cytotoxic behavior in cancer cells in vitro but losing efficacy in vivo, and in many cases, this is the result of poorly understood chemoresistant effects conferred by the cancer microenvironment. To address this, improved methods for culturing cancer cells in biomimetic scaffolds have been developed; along the way, a great deal about the nature of cancer cell-extracellular matrix (ECM) interactions has been discovered. These discoveries will continue to be leveraged both in the development of novel drugs targeting these interactions and in the fabrication of biomimetic substrates for efficient cancer drug screening in vitro. (C) 2015 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available